This new review from Baris Ata & Erkan Kalafat concludes that progestin primed ovarian stimulation represents a more patient friendly and cost-effective choice for oocyte or embryo cryopreservation cycles. Read it for free from our in-press articles now https://t.co/NeYmhhbtnU https://t.co/oTK3Qb5hHt
Progestin-primed ovarian stimulation: for whom, when and how?
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2023 – Mar 2024Where it's discussed
-
X / Twitter2 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions mainly focus on the positive aspects highlighted in the review, such as patient-friendliness and cost savings, with language like 'more patient-friendly' and 'cost-effective' signaling broad applicability. The tone is generally supportive and informative, indicating a shared interest in improving reproductive treatments based on the findings.
Most discussions endorse the article, emphasizing its conclusions that progestin-primed ovarian stimulation is beneficial for patients.
Participants show moderate curiosity, highlighting the new review's benefits and practical implications.
Comments reflect a thoughtful engagement with the topic, mentioning cost-effectiveness and patient-centered approaches.
The discourse suggests recognition of the publication’s potential influence on clinical practices and patient choices.
Top posts
Most liked on X and BlueskyRT @RBMOnline: This new review from Baris Ata & Erkan Kalafat concludes that progestin primed ovarian stimulation represents a more patient…
All mentions
Progestin-Primed Ovarian Stimulation: Indications, Timing, and Methods
RBMO Communications Editor Simon Brown discusses with Prof Dr Baris Ata the use of progestin-primed ovarian stimulation, exploring patient suitability, endocrinology, advantages over GnRH analogues, and practical…
RT @RBMOnline: This new review from Baris Ata & Erkan Kalafat concludes that progestin primed ovarian stimulation represents a more patient…
This new review from Baris Ata & Erkan Kalafat concludes that progestin primed ovarian stimulation represents a more patient friendly and cost-effective choice for oocyte or embryo cryopreservation cycles. Read it for free from our in-press articles now https://t.co/NeYmhhbtnU https://t.co/oTK3Qb5hHt
RO
BA